Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-sequence facilitates analyze changes of signaling pathways after drug treatment

ABSTRACT: RNA-sequence facilitates analyze changes of signaling pathways after drug treatment

PROVIDER: PRJNA579963 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

RNA-sequence facilitates analyze changes of signaling pathways after cell reprogramming

Project description:RNA-sequence facilitates analyze changes of signaling pathways after cell reprogramming

| PRJNA1018964 | ENA

RNA-sequence facilitates analyze changes of signaling pathways after drug treatment

Project description:Mammalian cochlear hair cells cannot regenerate after damage, which was a cause of hearing loss. Due to the small number of cochlear hair cells, we were unable to collect enough cells for research. Therefore, we have established a inner ear organoid model in this way, which greatly expands the number of supporting cells, Lgr5 and gradually mature hair cells. It can be used in high-throughput screening experiments. Using this model for high-throughput screening of FDA small molecule Drug, we found that Regorafenib can promote hair cell regeneration in vitro and get more mature regenerated hair cells. And we found that Regorfenib was though a new VEGF-TGFB axis to regulate hair cell regeneration.

2019-10-29 | GSE139485 | GEO

RNA-sequence facilitates analyze changes of P3 Plscr5 knockout mice

Project description:RNA-sequence facilitates analyze changes of P3 Plscr5 knockout mice

| PRJNA1150924 | ENA

RNA-sequence facilitates analyze changes of signaling pathways after cell reprogramming

Project description:Cochlear hair cells are the sensory cells responsible for transduction of acoustic signals. In mammals, damaged hair cells do not regenerate, resulting in permanent hearing loss. Reprogramming of the surrounding supporting cells to functional hair cells represent a novel strategy to hearing restoration. However, cellular processes governing the efficient and functional hair cell reprogramming are not completely understood. Employing the mouse cochlear organoid system, we performed detailed metabolomic characterizations of the expanding and differentiating organoids. We found that hair cell differentiation is associated with increased mitochondrial electron transport chain (ETC) activity and reactive oxidative species generation. Transcriptome and metabolome analyses indicate reduced expression of oxidoreductases and tricyclic acid (TCA) cycle metabolites. The metabolic decoupling between ETC and TCA cycle limits the availability of the key metabolic cofactors, α-ketoglutarate and NAD+. Reduced expression of NAD+ in cochlear supporting cells by PGC1α deficiency further impairs hair cell reprogramming, while supplementation of α-ketoglutarate and NAD+ promotes hair cell reprogramming both in vitro and in vivo. Our findings reveal metabolic rewiring as a central cellular process during hair cell differentiation, and highlight the insufficiency of key metabolites as a metabolic barrier for efficient hair cell reprogramming.

2024-09-20 | GSE243581 | GEO

Mitochondria-localized MBD2c facilitates mtDNA transcription and drug resistance

Project description:Mitochondria-localized MBD2c facilitates mtDNA transcription and drug resistance

| PRJNA1100414 | ENA

RNA-sequence facilitates analyze changes of P3 Plscr5 knockout mice

Project description:We report application of RNA-seq for transcriptomic analyses of cochlear tissues from wildtype and Plscr5 knockout mice to reveal gene expressions altered by Plscr5 knock out

2024-08-31 | GSE275440 | GEO

Mitochondria-localized MBD2c facilitates mtDNA transcription and drug resistance [Bisulfite-Seq]

Project description:Mitochondria-localized MBD2c facilitates mtDNA transcription and drug resistance [Bisulfite-Seq]

| PRJNA1127994 | ENA

Drug treatment comparison

Project description:H460 cells were treated with 5-FU, cytarabin, cisplatin, paclitaxel, and cytochalasin D. Gene expression changes induced by drug treatment were compared.

2010-06-10 | E-GEOD-2182 | biostudies-arrayexpress

Induction of Multiple Alternative Mitogenic Signaling Pathways Accompanies Emergence of Slowly Growing Drug-Tolerant Cancer Cells

Project description:Drug resistance continues to be a major obstacle to curing cancer. Resistance can evolve from a subpopulation of cancer cells that initially survive drug treatment and then gradually form a pool of slowly growing drug-tolerant cells. Several studies have pinpointed activation of a specific bypass pathway that appears to provide the critical therapeutic target for preventing drug tolerance. Here we take a systems-biology approach using proteomics and genomics to examine the development of drug tolerance to EGFR inhibitors in EGFR-mutant lung adenocarcinoma cells and BRAF inhibitors in BRAF-mutant melanoma cells. We found that there are numerous alternative mitogenic pathways that become activated in both cases, including YAP, STAT3, IGFR1, and phospholipase C (PLC)/protein kinase C (PKC) pathways. Our results suggest that an effective therapeutic strategy to prevent drug tolerance will need to take multiple alternative mitogenic pathways into account rather than focusing on one specific pathway.

2021-01-31 | GSE162045 | GEO

Drug treatment comparison

Project description:H460 cells were treated with 5-FU, cytarabin, cisplatin, paclitaxel, and cytochalasin D. Gene expression changes induced by drug treatment were compared. Keywords: other

2005-01-27 | GSE2182 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data